Evaluation of a Lightweight Nasal Interface and Ventilator for Use by Patients With Respiratory Disease
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 20
- 主要终点
- Exercise Endurance Time to Maximum Tolerance
研究概览
简要总结
A preliminary study to evaluate a new nasal interface and portable ventilator system in comparison to standard oxygen therapy in patients with severe chronic lung disease.
详细描述
An open-label, randomized, controlled, crossover study in patients with severe chronic lung disease to evaluate exercise tolerance compared to standard nasal cannula oxygen therapy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult male or female (> 18 years of age) with a diagnosis of severe-to-very severe chronic lung disease
- •Participates in a qualified pulmonary rehabilitation program
- •Requires constant flow oxygen of ≥ 2 LPM (liters per minute) during exercise
- •Able and willing to sign the informed consent
- •Ability to be fitted with the test nasal mask and to use the test ventilator system
排除标准
- •Requires > 5LPM of constant flow to maintain SpO2> 90% during exercise
- •Reports having serious epistaxis within the last 14 days prior to enrollment
- •Currently enrolled in another clinical study or has participated within 30 days of enrollment
- •Has any condition or abnormality that in the opinion of the Investigators may compromise the participant's safety or the quality of the study data
结局指标
主要结局
Exercise Endurance Time to Maximum Tolerance
时间窗: Maximum exercise endurance in minutes, for both treatment arms. Two 4-hr study visits, 1 week apart. Endurance endpoint will be evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.
Endurance measured on cycle ergometer at predetermined constant work rate. Subjects will exercise to their limit of tolerability (max effort).
次要结局
- Borg 10 Dyspnea Score, Subject reported(Recorded 1-2 min before and every 1 min during exercise testing. Two 4-hr study visits, scheduled 1 week apart. Endpoint will be evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.)
- Arterial Oxygen Saturation via Pulse Oximeter (SpO2)(Recorded 1-2 min before and every 1 minute during exercise testing. Two 4-hr study visits, scheduled 1 week apart. Endpoint will be evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.)
- Heart Rate(Recorded 1-2 min before and every 1 min during exercise testing. Two 4-hr study visits, scheduled 1 week apart. Endpoint will be evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.)
- Leg Fatigue, Subject Reported(Recorded 1-2 min before and every 1 min during exercise testing. Two 4-hr study visits, scheduled 1 week apart. Endpoint will be evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.)
- Adverse Events(Two 4-hr study visits, sheduled 1 week apart. Subjects will be monitored for AEs continuously throughuout the study visit. AEs will be monitored and recored during both study visits.)
- Respiratory Rate(Recorded 1-2 min before and every 1 min during exercise. Evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.)
